ArticleNature communications2024
Development of a RIPK1 degrader to enhance antitumor immunity.
Xin Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it
ArticleNature communications2024
Xin Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.